Section of Molecular Medicine, Department of Medicine, Oklahoma City, Oklahoma 73013.
Section of Molecular Medicine, Department of Medicine, Oklahoma City, Oklahoma 73013; Department of Biochemistry and Molecular Biology, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma 73013.
J Biol Chem. 2013 Jun 7;288(23):16495-16505. doi: 10.1074/jbc.M112.443580. Epub 2013 Apr 23.
Two splice variants of LKB1 exist: LKB1 long form (LKB1(L)) and LKB1 short form (LKB1(S)). In a previous study, we demonstrated that phosphorylation of Ser-428/431 (in LKB1(L)) by protein kinase Cζ (PKCζ) was essential for LKB1-mediated activation of AMP-activated protein kinase (AMPK) in response to oxidants or metformin. Paradoxically, LKB1S also activates AMPK although it lacks Ser-428/431. Thus, we hypothesized that LKB1(S) contained additional phosphorylation sites important in AMPK activation. Truncation analysis and site-directed mutagenesis were used to identify putative PKCζ phosphorylation sites in LKB1(S). Substitution of Ser-399 to alanine did not alter the activity of LKB1(S), but abolished peroxynitrite- and metformin-induced activation of AMPK. Furthermore, the phosphomimetic mutation (S399D) increased the phosphorylation of AMPK and its downstream target phospho-acetyl-coenzyme A carboxylase (ACC). PKCζ-dependent phosphorylation of Ser-399 triggered nucleocytoplasmic translocation of LKB1(S) in response to metformin or peroxynitrite treatment. This effect was ablated by pharmacological and genetic inhibition of PKCζ, by inhibition of CRM1 activity and by substituting Ser-399 with alanine (S399A). Overexpression of PKCζ up-regulated metformin-mediated phosphorylation of both AMPK (Thr-172) and ACC (Ser-79), but the effect was ablated in the S399A mutant. We conclude that, similar to Ser-428/431 (in LKB1(L)), Ser-399 (in LKB1(S)) is a PKCζ-dependent phosphorylation site essential for nucleocytoplasmic export of LKB1(S) and consequent AMPK activation.
两种 LKB1 的剪接变体存在:LKB1 长形式(LKB1(L))和 LKB1 短形式(LKB1(S))。在之前的研究中,我们证明了蛋白激酶 Cζ(PKCζ)对 Ser-428/431(在 LKB1(L)中)的磷酸化对于 LKB1 介导的氧化应激或二甲双胍反应中 AMP 激活蛋白激酶(AMPK)的激活是必不可少的。矛盾的是,尽管 LKB1S 缺乏 Ser-428/431,但它也能激活 AMPK。因此,我们假设 LKB1(S) 包含在 AMPK 激活中很重要的其他磷酸化位点。截断分析和定点突变用于鉴定 LKB1(S) 中潜在的 PKCζ 磷酸化位点。Ser-399 突变为丙氨酸不会改变 LKB1(S)的活性,但会消除过氧亚硝酸盐和二甲双胍诱导的 AMPK 激活。此外,磷酸模拟突变(S399D)增加了 AMPK 及其下游靶标磷酸化乙酰辅酶 A 羧化酶(ACC)的磷酸化。PKCζ 依赖性 Ser-399 磷酸化触发 LKB1(S) 的核质易位,以响应二甲双胍或过氧亚硝酸盐处理。这种效应被 PKCζ 的药理学和遗传抑制、CRM1 活性的抑制以及用丙氨酸(S399A)取代 Ser-399 所消除。PKCζ 的过表达上调了二甲双胍介导的 AMPK(Thr-172)和 ACC(Ser-79)的磷酸化,但在 S399A 突变体中这种效应被消除。我们得出结论,类似于 Ser-428/431(在 LKB1(L)中),Ser-399(在 LKB1(S)中)是 PKCζ 依赖性磷酸化位点,对于 LKB1(S)的核质输出和随后的 AMPK 激活是必不可少的。